Literature DB >> 1921230

Nocturnal myocardial ischemia and cardiac arrhythmia in patients with sleep apnea with and without coronary heart disease.

U Koehler1, H Dübler, T Glaremin, H Junkermann, C Lübbers, T Ploch, J H Peter, T Pomykaj, P von Wichert.   

Abstract

To study the effect of apnea and hypoventilation-induced hypoxemia on the heart, we carried out polysomnographic recordings over 4 nights with electrocardiographic tracings in 30 patients with and without coronary heart disease. Evaluations of the data were based on the 2nd and 4th nights. In six subjects, five with coronary heart disease, we found 85 episodes of nocturnal ischemia, mainly during REM sleep (83.5%), high apnea activity, and sustained and progressive hypoxemia. Complex ventricular ectopy was observed in 14/13 patients (nights 2/4) and repetitive ventricular ectopy in 5/3. There was no significant difference in the quality and quantity of ventricular ectopy during wake and sleep states between the CHD group and the control group. In one patient ventricular bigeminy was observed only at a threshold of SaO2 below 60%. Bradyarrhythmia was made evident in four subjects from the CHD group and correlated mainly with apnea activity. We suppose that patients with sleep apnea and CHD are at cardiac risk because coronary heart disease can be aggravated by insufficient arterial oxygen supply due to cumulative phase of apnea and hypoventilation. The reduced hypoxic tolerance of the heart may lead to myocardial ischemia and increased electrical instability.

Entities:  

Mesh:

Year:  1991        PMID: 1921230     DOI: 10.1007/bf01649418

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  20 in total

1.  Mechanism of early "pump" failure of the ischemic heart: possible role of adenosine triphosphate depletion and inorganic phosphate accumulation.

Authors:  W Kübler; A M Katz
Journal:  Am J Cardiol       Date:  1977-09       Impact factor: 2.778

2.  Cardiac arrhythmias in hospitalized patients with chronic obstructive pulmonary disease.

Authors:  F D Holford; J C Mithoefer
Journal:  Am Rev Respir Dis       Date:  1973-10

3.  Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina.

Authors:  A N Nicolaides; T Horbourne; R Bowers; P H Kidner; E M Besterman
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

4.  Myocardial high energy phosphate stores in acutely induced hypoxic heart failure.

Authors:  P E Pool; J W Covell; C A Chidsey; E Braunwald
Journal:  Circ Res       Date:  1966-08       Impact factor: 17.367

Review 5.  Is snoring a cause of vascular disease? An epidemiological review.

Authors:  P C Waller; R S Bhopal
Journal:  Lancet       Date:  1989-01-21       Impact factor: 79.321

Review 6.  Cardiovascular effects of sleep disorders.

Authors:  J M Parish; J W Shepard
Journal:  Chest       Date:  1990-05       Impact factor: 9.410

7.  Nocturnal vs diurnal cardiac arrhythmias in patients with chronic obstructive pulmonary disease.

Authors:  M R Flick; A J Block
Journal:  Chest       Date:  1979-01       Impact factor: 9.410

8.  Snoring as a risk factor for hypertension and angina pectoris.

Authors:  M Koskenvuo; J Kaprio; M Partinen; H Langinvainio; S Sarna; K Heikkilä
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

Review 9.  The heart cell: some metabolic aspects of cardiac arrhythmias.

Authors:  W G Nayler
Journal:  Acta Med Scand Suppl       Date:  1981

10.  Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.

Authors:  P D Hirsh; L D Hillis; W B Campbell; B G Firth; J T Willerson
Journal:  N Engl J Med       Date:  1981-03-19       Impact factor: 91.245

View more
  4 in total

Review 1.  Heart block in patients with sleep apnoea.

Authors:  H F Becker; U Koehler; A Stammnitz; J H Peter
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

2.  Cluster analysis: A new technology for the evaluation of oximetry and airflow waveforms in obstructive sleep apnea.

Authors:  L A Lynn
Journal:  Sleep Breath       Date:  1997-12       Impact factor: 2.816

Review 3.  Sleep-related breathing disorders. 4. Consequences of sleep disordered breathing.

Authors:  K A Ferguson; J A Fleetham
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

4.  Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease.

Authors:  Elena Nobili; M Dolores Salvado; Lasse Folkersen; Laura Castiglioni; Jens Kastrup; Anders Wetterholm; Elena Tremoli; Göran K Hansson; Luigi Sironi; Jesper Z Haeggström; Anders Gabrielsen
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.